In the presence of each TME mimetic, SpiD3 induced PARP cleavage, decreased oncogenic MYC expression, and reduced levels of MCL1, an antiapoptotic protein contributing to CLL drug resistance (ref. 7; Fig. 3F and G; Supplementary Fig. S6B). Here, MYC is linked to B-cell chronic lymphocytic leukemia.